Showing results (71-80 of 94) with videos related to
Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|May 31, 2008
Discovery and initial SAR of arylsulfonylpiperazine inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1)Daqing Sun, Zhulun Wang, Yongmei Di, et al.Journal of Medicinal Chemistry|July 6, 2019
Discovery of a Potent Steroidal Glucocorticoid Receptor Antagonist with Enhanced Selectivity against the Progesterone and Androgen Receptors (OP-3633)Xiaohui Du, John Eksterowicz, Haiying Zhou, et al.Bioorganic & Medicinal Chemistry Letters|November 4, 2015
Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4Zhulun Wang, Daqing Sun, Sheree Johnstone, et al.Bioorganic & Medicinal Chemistry Letters|February 17, 2009
Discovery and optimization of piperidyl benzamide derivatives as a novel class of 11beta-HSD1 inhibitorsYosup Rew, Dustin L McMinn, Zhulun Wang, et al.Journal of Cancer Research and Therapeutics|September 4, 2025
Effect of radical radiotherapy dose on the prognosis of limited-stage thoracic small cell carcinoma of the esophagus: A multicenter retrospective trial from China (CHiSCEC)Zhanyuan Li, Qi Zhang, Qifeng Wang, et al.Bioorganic & Medicinal Chemistry|September 16, 2008
Distinctive molecular inhibition mechanisms for selective inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1Hua Tu, Jay P Powers, Jinsong Liu, et al.Bioorganic & Medicinal Chemistry Letters|February 3, 2009
Synthesis and optimization of arylsulfonylpiperazines as a novel class of inhibitors of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)Daqing Sun, Zhulun Wang, Mario Cardozo, et al.International Journal of Surgery (London, England)|November 23, 2023
Surgery versus radiotherapy for limited-stage small cell esophageal carcinoma: a multicenter, retrospective, cohort study in China (ChiSCEC)Jie Zhu, Yi Wang, Hongfu Sun, et al.Journal of Medicinal Chemistry|August 10, 2018
Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101)Yosup Rew, Xiaohui Du, John Eksterowicz, et al.Bioorganic & Medicinal Chemistry Letters|October 26, 2010
The synthesis and SAR of novel diarylsulfone 11β-HSD1 inhibitorsXuelei Yan, Zhulun Wang, Athena Sudom, et al.Pageof 10